Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Mirum Pharmaceuticals, Inc. (MIRM) had Days Sales in Receivables of 75.25 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$127.78M |
|
$-5.86M |
|
$23.42M |
|
$104.36M |
|
$132.77M |
|
$-4.99M |
|
$-0.47M |
|
$-5.46M |
|
$-5.46M |
|
$-5.86M |
|
$-5.86M |
|
$-5.86M |
|
$-5.86M |
|
$-4.99M |
|
$1.49M |
|
49.73M |
|
49.73M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$453.40M |
|
$1.18M |
|
$272.43M |
|
$725.83M |
|
$144.80M |
|
$308.93M |
|
$325.87M |
|
$470.67M |
|
$255.16M |
|
$17.29M |
|
$255.16M |
|
50.06M |
|
| Cash Flow Statement Financials | |
$10.08M |
|
$-22.73M |
|
$15.05M |
|
$222.93M |
|
$228.60M |
|
$5.67M |
|
$34.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.13 |
|
-- |
|
-- |
|
0.55 |
|
1.21 |
|
81.67% |
|
-3.90% |
|
-3.90% |
|
-- |
|
-4.27% |
|
-4.59% |
|
$9.91M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
1.02 |
|
1.20 |
|
|
Days Sales in Receivables |
75.25 |
-2.30% |
|
-33.90% |
|
-0.81% |
|
-1.04% |
|
$5.10 |
|
$0.20 |
|
$0.20 |
|